Argenx

ARGX NASDAQ
133.79
+7.86
+6.24%
After Hours: 133.79 0 0.00% 16:00 06/18 EDT
Open
127.71
Prev Close
125.93
High
133.90
Low
127.69
Volume
180.23K
Avg Vol (3M)
171.03K
52 Week High
137.50
52 Week Low
63.81
% Turnover
0.47%
Market Cap
5.04B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Argenx ARGX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.
MORE >

Recently

Name
Price
%Change